Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save this grant

Next deadline: Feb 14, 2023 (Full proposal)

Later deadlines: May 14, 2023 (Letter of inquiry), Jun 14, 2023 (Full proposal), Sep 17, 2023 (Letter of inquiry), Oct 17, 2023 (Full proposal), Jan 14, 2024 (Letter of inquiry), Feb 14, 2024 (Full proposal), May 14, 2024 (Letter of inquiry), Jun 14, 2024 (Full proposal), Sep 17, 2024 (Letter of inquiry), Oct 17, 2024 (Full proposal), Jan 14, 2025 (Letter of inquiry), Feb 14, 2025 (Full proposal), May 14, 2025 (Letter of inquiry), Jun 14, 2025 (Full proposal), Sep 14, 2025 (Letter of inquiry), Oct 14, 2025 (Full proposal)

Grant amount: Up to US $4,000,000

Fields of work: Cancer/Oncology

Applicant type: Government Entity, Nonprofit, For-Profit Business, Indigenous Group

Funding uses: Research

Location of project: United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico Show all

Location of residency: United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico Show all

Overview:

Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) intends to accelerate the development of evidence-based cancer-related interventions to improve health equity and reflect the diversity of people, places, contexts, and settings in the United States. Specifically, this FOA will support research that tests the impact of cancer-related interventions on cancer-related outcomes across the cancer control continuum using a pragmatic trial study design. This FOA will use the UG3/UH3 phased cooperative agreement mechanism. The UG3 phase will support refining the cancer-related intervention and finalizing study-related activities in preparation for conducting the pragmatic trial during the UH3 phase.

Application budgets may not exceed $500,000 in direct costs per year for the UG3 phase and may not exceed $750,000 in direct costs per year for the UH3 phase. The maximum project period is two years for the UG3 phase and four years for the UH3 phase. 

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

This page was last reviewed November 30, 2022 and last updated November 30, 2022